2020
DOI: 10.1101/2020.05.06.080150
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis

Abstract: 223 words Introduction 533 words = 3995 words Methods 375 words Results 2382 words References 49 references Key Points • Patient-derived KIT D816V iPSCs and CRISPR-engineered KIT D816V ESCs model SM disease heterogeneity and serve as drug screening platform • Nintedanib selectively targets KIT D816V iPSC-and ESC-derived cells and primary samples of SM patients Primary Scientific Category: Myeloid neoplasia Abstract The KIT D816V mutation is found in more than 80% of patients with systemic mastocytosis (SM) and… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Five human iPSC-lines were generated from mesenchymal stromal cells (iPSC-102, iPSC-104, and iPSC-106) or blood (PT4-WT4, PT18-WT18; Toledo et al, 2020) by reprogramming with episomal plasmids or sendai virus, respectively. The study was approved by the local ethic committee and all samples were taken after written consent (EK206/09).…”
Section: Methodsmentioning
confidence: 99%
“…Five human iPSC-lines were generated from mesenchymal stromal cells (iPSC-102, iPSC-104, and iPSC-106) or blood (PT4-WT4, PT18-WT18; Toledo et al, 2020) by reprogramming with episomal plasmids or sendai virus, respectively. The study was approved by the local ethic committee and all samples were taken after written consent (EK206/09).…”
Section: Methodsmentioning
confidence: 99%